Paul Conkling Selected Research

4- imino- 1,3- diazabicyclo(3.1.0)hexan- 2- one

1/2018	A Phase 2 Randomized, Double-Blind, Multicenter Trial of Imexon Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy-naïve Pancreatic Adenocarcinoma.
7/2010	A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul Conkling Research Topics

Disease

8	Neoplasms (Cancer) 01/2021 - 01/2013
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020 - 05/2004
3	Disease Progression 01/2021 - 11/2014
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 06/2006
3	Neutropenia 10/2018 - 01/2011
3	Adenocarcinoma 01/2018 - 07/2010
2	Nausea 01/2021 - 07/2014
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 10/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2018
1	Hematologic Neoplasms (Hematological Malignancy) 10/2018
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2018
1	Multiple Myeloma 01/2017
1	Injection Site Reaction 07/2014
1	Fatigue 07/2014
1	Pruritus (Itching) 07/2014
1	Thrombocytopenia (Thrombopenia) 01/2011
1	Pancreatic Neoplasms (Pancreatic Cancer) 07/2010
1	Cardiotoxicity 05/2010
1	Exanthema (Rash) 06/2006
1	Dyspnea (Shortness of Breath) 06/2006

Drug/Important Bio-Agent (IBA)

3	atezolizumabIBA 01/2021 - 01/2019
3	PlatinumIBA 08/2014 - 05/2010
2	B7-H1 AntigenIBA 01/2021 - 01/2020
2	Docetaxel (Taxotere)FDA Link 01/2019 - 06/2006
2	4- imino- 1,3- diazabicyclo(3.1.0)hexan- 2- oneIBA 01/2018 - 07/2010
2	Gemcitabine FDA Link 01/2018 - 07/2010
2	Monoclonal AntibodiesIBA 12/2014 - 11/2014
2	Bevacizumab (Avastin)FDA Link 08/2014 - 01/2013
2	amrubicinIBA 01/2011 - 05/2010
2	Carboplatin (JM8)FDA LinkGeneric 06/2006 - 05/2004
1	elacestrantIBA 01/2021
1	Estrogen ReceptorsIBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	Phosphorus (Red Phosphorus)IBA 01/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	RAD1901IBA 01/2021
1	TabletsIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	cc-486IBA 10/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2018
1	Azacitidine (5 Azacytidine)FDA Link 10/2018
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2017
1	carfilzomibIBA 01/2017
1	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2014
1	LigandsIBA 12/2014
1	TovetumabIBA 11/2014
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 11/2014
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2014
1	Toll-Like Receptor 9IBA 08/2014
1	IMO-2055IBA 08/2014
1	ElectrolytesIBA 08/2014
1	Peptides (Polypeptides)IBA 07/2014
1	LY2510924IBA 07/2014
1	Pharmaceutical PreparationsIBA 07/2014
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2013
1	Messenger RNA (mRNA)IBA 01/2013
1	Capecitabine (Xeloda)FDA Link 01/2013
1	Neuropilin-1IBA 01/2013
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2011
1	aziridine (ethyleneimine)IBA 07/2010
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2004
1	thiamine triphosphorate (TTP)IBA 05/2004

Therapy/Procedure

5	Therapeutics 01/2020 - 05/2010
4	Drug Therapy (Chemotherapy) 01/2018 - 01/2011
1	Castration 01/2021
1	Regimen B 07/2010
1	Radiotherapy 06/2006